Left Ventricular Hypertrophy Diagnosed with Transthoracic Echocardiography and its Relationship with Electrocardiographic Changes
DOI:
https://doi.org/10.18041/2390-0512/biociencias.2.9656Keywords:
Left ventricular hypertrophy, hypertension, echocardiography, electrocardiographyAbstract
Objective: To evaluate left ventricular hypertrophy diagnosed with transthoracic echocardiography and its relationship with electrocardiographic changes. Methods: An analytical observational study was carried out in patients treated by the cardiology service at the General Hospital of Barranquilla MiRed IPS, from October 2020 to March 2021. Results: From a total of 111 patients, 63.1% (n = 70) were female, the mean age was 64.1 ± 11.8; 21.6% (n = 24) had hypercholesterolemia, 26.1% (n = 29) took 3-hour weekly walks, and 44.1% (n = 49) were obese. 90.1% (n = 100) received treatment, being losartan the most widely used with 52.3% (n = 58), 77.5% (n = 86) complied with the treatment, and 67.6 % (n = 75) showed normal creatinine values 0-1.0 mg / dL. A significant difference was established between the categories of the electrocardiographic patterns, 39.0% (n = 30) with left ventricular hypertrophy had poor R wave progression in V3 (p <0.000), and those who did not show ventricular hypertrophy left, had other electrocardiographic findings 67.6% (n = 67), (p <0.000). The patients with concentric hypertrophy pattern corresponded to 76.6% (n = 59), (p <0.000) those with eccentric hypertrophy had the electrocardiographic record with Sokolow-Lyon index 16.2% (n = 18). None of the electrocardiographic findings was sufficiently accurate in estimating left ventricular hypertrophy. Conclusion: Low sensitivity in the electrocardiographic indices for the diagnosis of left ventricular hypertrophy is reported in this study, with a great difference in its diagnostic power compared to echocardiogram.
Downloads
References
Fernández J, Maestro F, Allut G, Grigorian L, Otero F y González J. Elevada prevalencia de HVI en pacientes con HTA de larga evolución. Med Clin (Barc). 2007;129(2):46-50.
Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation AHA 55:613-618, 1977.
Mills K , Bundy , Kelly T, Reed J, Kearney P , Reynolds R , et al. Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies From 90 Countries. Circulation. 2016;134(6):441-450.
Artham S, .Lavie C, Milani R, Patel D, Verma A, Ventura H. Clinical Impact of Left Ventricular Hypertrophy and Implications for Regression, J.pcad (2009) 153–167.
Bang C, Soliman E, Simpson L , Davis B Devereux R. Electrocardiographic left ventricular hypertrophy predicts cardiovascular morbidity and mortality in hypertensive patients: The ALLHAT study. Am J Hypertens 2017;30(9):914-922.
Bressman M, Mazori A, Shulman E, Chudow J, Goldberg Y, Ferrick K. et. Al. Impact of patient characteristics on sensitivity and specificity for left ventricular hypertrophy by ecg in a large, diverse patient population. 1728 JACC, 2019 Volume 73, Issue 9.
Iribarren C; Round A;Lu M; Okin P. McNulty E. Cohort Study of ECG Left Ventricular Hypertrophy Trajectories: Ethnic Disparities, Associations With Cardiovascular Outcomes, and Clinical Utility. Jaha. ahajournals.2017.
Colosimo A, Costa F, Riera A, Bombig M, Lima V. Fonseca F. Electrocardiogram Sensitivity in Left Ventricular Hypertrophy According to Gender and Cardiac Mass. Arq Bras Cardiol 2011; 97(3): 225-231).
Cao X, Broughton, S, Waits G, Nguyen T, Li Y, Soliman E, Interrelations Between Hypertension and Electrocardiographic Left Ventricular Hypertrophy and Their Associations with Cardiovascular Mortality. Am J Cardiol 2019; 123:274−283.
Denis D, Martínez S, Figueredo A, Rodríguez E. Valor diagnóstico de la R de aVL en la hipertrofia ventricular izquierda. Univ Méd Pinareña. Enero-abril 2020; 16(1): e382
Manrique F, Ospina J, X Herrera-Amaya G Prevalencia de HVI en pacientes hipertensos. Amc. 2014; 39: 244-249.
Castaño J, Giraldo J, Meza L, Muñoz J, Ramírez A, Rojas C, et al, Hallazgos electrocardiográficos en pacientes hipertensos del programa de vigilancia y control de la HTA de ASSBASALUD ESE, Manizales, Colombia. Rev. Fac. yMed. 2014 vol. 62 No. 1: 81-90.
Jiang X, Quan X, Yang J, Zhou X, Hu A, Zhang Y. Electrocardiographic criteria for the diagnosis of abnormal hypertensive cardiac phenotypes. J Clin Hypertens. 2019;1–7.
Cuspidi C, Facchetti R, Bombelli M, Tadic M, Sala C, Grassi G. High Normal Blood Pressure and Left Ventricular Hypertrophy Echocardiographic Findings from the PAMELA Population. Hypertension AHA. 2019.
Bressman M, Mazori A, Shulman E, Chudow J, Goldberg Y, Ferrick K. Diagnosing left ventricular hypertrophy in a large, diverse patient population: ecg versus echo. 1727 JACC. 2019 Volume 73, Issue 9.
Cuspidi C, Sala C, Negri F, Mancia G, Morganti A. Italian Society of Hypertension. Prevalence of left-ventricular hypertrophy in hypertension: an updated review ofechocardiographic studies. J Hum Hypertens 2012;26(6):343-349.
Manrique A, Ospina J., Herrera M. Prevalencia de HVI en pacientes hipertensos de Boyacá, Colombia. Amc, 39(3), 244-249.
Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018; 36:1953–2041.
Marwick T, Gillebert T, Aurigemma G , Julio C, Derumeaux G, Galderisi M et al. Recommendations on the use of echocardiography in adult hypertension: a report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE). J Am Soc Echocardiogr 2015; 28:727-754.
Gonzalez A., Ravassa S., Lopez B., Moreno M. Beaumont J., San Jose G., et al. myocardial remodeling in hypertension toward a new view of hypertensive heart disease. Hypertension AHA 2018;72(3):549-558.
Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018; 36:1953–2041.
Whelton P. Carey R, Casey D, Collins K. Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/ APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary. J Am Soc Hypertens 2018; 12(8): 579.e1-579.e73.
Unger T, Borghi C, Charchar F, Khan N, Poulter N, Prabhakaran D, et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines, Hypertension. 2020; 75:00-00.
Hsieh BP, Pham MX, Froelicher VF. Prognostic evalue of electrocardiographic criteria for left ventricular hypertrophy. Am Heart J. 2005; 150:161‐167.
Bacharova L, Schocken D, Edward H, Strauss D, Strauss Estes. The Role of ECG in the Diagnosis of Left Ventricular Hypertrophy Curr. Cardiol Rev, 2014, 10, 257-261.
Serratosa-Fernández L, Pascual-Figal D, Masiá-Mondéjar M, Sanz-de la Garza M, Madaria-Marijuan Z, Gimeno-Blanes J. Et Al.
Comentarios a los nuevos criterios internacionales para la interpretación del EKG del deportista. Rev Esp Cardiol. 2017; 70(11) :983–990.
Electrocardiographic detection of left ventricular hypertrophy development and prospective validation of improved criteria. J Am Coll Cardiol 1985; 6: 572-580.
Egan BM, Li J, Hutchison FN, Ferdinand KC. Hypertension in the United States,1999 to 2012. Circulation 2014;130(19):1692-1699.
Anttila I, Nikus K, Nieminen T, Jula A, Reunanen A, Salomaa V, et al. Prevalence and prognostic value of poor R-wave progression in standard resting electrocardiogram in a general adult population. The Health 2000 Survey, Ann. Med. 2010; 42: 135–142.
Bang CN, Soliman EZ, Simpson LM, Davis B, Devereux R, Okin P. Electrocardiographic left ventricular hypertrophy predicts cardiovascular morbidity and mortality in hypertensive patients: the ALLHAT study. Am J Hypertens 2017;30(9):914-922.
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Biociencias
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
-
Reconocimiento — Debe reconocer adecuadamente la autoría, proporcionar un enlace a la licencia e indicar si se han realizado cambios<. Puede hacerlo de cualquier manera razonable, pero no de una manera que sugiera que tiene el apoyo del licenciador o lo recibe por el uso que hace.
-
NoComercial — No puede utilizar el material para una finalidad comercial.
-
CompartirIgual — Si remezcla, transforma o crea a partir del material, deberá difundir sus contribuciones bajo la misma licencia que el original.
- No hay restricciones adicionales — No puede aplicar términos legales o medidas tecnológicas que legalmente restrinjan realizar aquello que la licencia permite.
